Latest Quarter
2026-03-31
Advanced Biomed Inc Common Stock (ADVB)
Revenue
$0.0
Net Income
-$15.5K
Operating Margin
N/A
Free Cash Flow
-$182K
Debt / Assets
46.6%
Values are in USD and rounded to the nearest whole number unless noted.
Swipe horizontally to view all columns.
| Income Statement (Quarterly) | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-03-31 |
|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 |
| Cost of Revenue | 295 | 466 | 0 | 0 |
| Gross Profit | -294 | -465 | 0 | 0 |
| Operating Expenses | ||||
| R&D Expenses | 0 | 0 | 0 | 0 |
| SG&A Expenses | 276,610 | 210,311 | 260,603 | 512,277 |
| Operating Expenses | 519,836 | 396,642 | 523,914 | 762,739 |
| Operating Income | -16,431 | -396,642 | -523,914 | 0 |
| Interest Expense | 4 | 0 | 0 | 0 |
| Income Before Tax | -15,455 | 7,002,178 | -386,901 | -1,383,874 |
| Income Tax Expense | 0 | 0 | 0 | 0 |
| Net Income | -15,455 | 6,857,921 | -386,901 | -1,383,874 |
| Per Share | ||||
| EPS | -0.01 | 0.31 | -0.02 | -0.07 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Statement (Annual) | 2025-06-30 | 2024-06-30 |
|---|---|---|
| Revenue | 0 | 0 |
| Cost of Revenue | 10,711 | 0 |
| Gross Profit | -10,711 | 0 |
| Operating Expenses | ||
| R&D Expenses | 0 | 0 |
| SG&A Expenses | 2,111,265 | 1,261,777 |
| Operating Expenses | 83,401 | 2,541,572 |
| Operating Income | -94,112 | -2,541,572 |
| Interest Expense | 0 | 0 |
| Income Before Tax | -101,524 | -2,782,278 |
| Income Tax Expense | 0 | 0 |
| Net Income | -101,524 | -2,782,278 |
| Per Share | ||
| EPS | -0.16 | -0.13 |
| EPS Diluted | 0.00 | 0.00 |
| Balance Sheet (Quarterly) | 2025-06-30 | 2024-06-30 |
|---|---|---|
| Assets | ||
| Cash and Cash Equivalents | 2,903,915,000 | 2,607,973 |
| Short Term Investments | 0 | 0 |
| Net Receivables | 7,956 | 6,324 |
| Inventory | 0 | -6,324 |
| Total Current Assets | 6,032,571,000 | 3,051,110 |
| Property Plant Equipment | 65,399,000 | 651,269 |
| Goodwill and Intangibles | 0 | 118,998 |
| Total Assets | 6,512,343,000 | 4,460,247 |
| Liabilities | ||
| Account Payables | 21,658 | 620,476 |
| Short Term Debt | 1,119,178 | 64,128 |
| Total Current Liabilities | 2,889,128,000 | 2,732,460 |
| Long Term Debt | 139,973 | 64,529 |
| Total Liabilities | 3,034,779,000 | 2,796,989 |
| Shareholders Equity | ||
| Retained Earnings | -19,233,044,000 | -15,974,074 |
| Total Shareholders Equity | 3,477,564,000 | 1,663,258 |
| Balance Sheet (Annual) | 2025-06-30 | 2024-06-30 |
|---|---|---|
| Assets | ||
| Cash and Cash Equivalents | 2,903,915,000 | 2,607,973 |
| Short Term Investments | 0 | 0 |
| Net Receivables | 7,956 | 6,324 |
| Inventory | 0 | -6,324 |
| Total Current Assets | 6,032,571,000 | 3,051,110 |
| Property Plant Equipment | 65,399,000 | 651,269 |
| Goodwill and Intangibles | 0 | 118,998 |
| Total Assets | 6,512,343,000 | 4,460,247 |
| Liabilities | ||
| Account Payables | 21,658 | 620,476 |
| Short Term Debt | 1,119,178 | 64,128 |
| Total Current Liabilities | 2,889,128,000 | 2,732,460 |
| Long Term Debt | 139,973 | 64,529 |
| Total Liabilities | 3,034,779,000 | 2,796,989 |
| Shareholders Equity | ||
| Retained Earnings | -19,233,044,000 | -15,974,074 |
| Total Shareholders Equity | 3,477,564,000 | 1,663,258 |
| Cash Flow Statement (Quarterly) | 2025-06-30 | 2024-06-30 |
|---|---|---|
| Operating Activities | ||
| Net Income | -101,524 | -2,782,278 |
| Depreciation & Amortization | 10,711 | 399,602 |
| Stock Based Compensation | 0 | 0 |
| Change in Working Capital | -90,650 | 256,336 |
| Operating Cash Flow | -181,464 | -2,126,340 |
| Investing Activities | ||
| Capital Expenditure | -985 | -74,110 |
| Investments | -985 | -74,110 |
| Investing Cash Flow | -985 | -74,110 |
| Financing Activities | ||
| Debt Repayment | 13,722 | 1,657,320 |
| Common Stock Issued/Repurchased | 171,144 | -2,682 |
| Dividends Paid | 0 | 0 |
| Financing Cash Flow | 184,867 | 1,866,820 |
| Summary | ||
| Free Cash Flow | -182,450 | -2,200,450 |
| Net Change in Cash | 19,018 | -14,306 |
| Cash Flow Statement (Annual) | 2025-06-30 | 2024-06-30 |
|---|---|---|
| Operating Activities | ||
| Net Income | -101,524 | -2,782,278 |
| Depreciation & Amortization | 10,711 | 399,602 |
| Stock Based Compensation | 0 | 0 |
| Change in Working Capital | -90,650 | 256,336 |
| Operating Cash Flow | -181,464 | -2,126,340 |
| Investing Activities | ||
| Capital Expenditure | -985 | -74,110 |
| Investments | -985 | -74,110 |
| Investing Cash Flow | -985 | -74,110 |
| Financing Activities | ||
| Debt Repayment | 13,722 | 1,657,320 |
| Common Stock Issued/Repurchased | 171,144 | -2,682 |
| Dividends Paid | 0 | 0 |
| Financing Cash Flow | 184,867 | 1,866,820 |
| Summary | ||
| Free Cash Flow | -182,450 | -2,200,450 |
| Net Change in Cash | 19,018 | -14,306 |